Zhao et al. demonstrated that miR-27a, PPARγ and ET-1 were cross-inhibited during the pathophysiological processes of PAH, which indicated that the miR-27a/PPARγ/ET-1 signalling pathway was dysregulated. The gene discussed is PPARG; the disease is pulmonary arterial hypertension.